| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |